No description available.

No description available.

Imprecise control of bovine oestrus and ovulation and the highly variable nature of the superovulatory response impedes use of reproductive technologies. The use of GnRH to control antral follicle development and, hence, the oestrous cycle was investigated using 40 maiden heifers. Two GnRH agonist sources (Fertagyl; Receptal) were tested at two frequencies (24; 48 hour) and luteinising hormone release profile; and pattern of antral follicle and luteal development were monitored. Post cessation of GnRH treatment gonadotrophin was given at either a fixed or variable time relative to oestrus and superovulatory response assessed. Basal LH values were unaffected by treatment. Treatment at 24, but not 48 hour intervals resulted in reduced LH response values. Fertagyl 24 hour treatment stimulated increased numbers of follicles to grow to 3-5 mm and 6-9 mm but inhibited growth to 10 mm, maturation and ovulation. Four waves of follicular development occurred in GnRH agonist, but not control, animals. Luteolysis and oestrus was delayed in a proportion of animals challenged with prostaglandin during GnRH agonist treatment. Exogenous gonadotrophin given at fixed time (day 10 1 where oestrus = day 0) post cessation of treatment, elicited a greater superovulatory response than when given at variable time. There was a positive relationship between number of ovulations and viable embryos; and a negative relationship between body weight and progesterone concentration and consequently superovulatory response. High superovulatory responses were observed when gonadotrophin treatment was initiated in the presence of an active corpus luteum and the absence of a dominant follicle. It was concluded that GnRH agonist given every 24 hours depleted LH reserves; allowed selection and dominance of antral follicles, but not maturation and ovulation; precluded prostaglandin induced luteolysis in some animals; and increased ovulations and embryos when gonadotrophin treatment was at a fixed time.

Poor reproductive performance is a major challenge for the bovine dairy industry, with implications for profitability and animal welfare. Early pregnancy diagnosis and accurate oestrus detection can improve reproductive performance through efficient herd management. However currently available methods do not allow this. Circulating microRNAs (miRNAs) have been proposed as non-invasive biomarkers of reproductive status in humans. The hypothesis for this work was that differentially expressed miRNAs in plasma will be detectable during early pregnancy / oestrus, which may provide novel potential biomarkers. Using sequencing and PCR-based platforms I successfully identified and validated increases in miR-26a and the miR-26a / miR-205 ratio as early as Day 8 of pregnancy (max. 7.5-fold) in the plasma of pregnant compared to non-pregnant heifers. These miRNAs are known regulators of immunity, angiogenesis and metabolism, however their specific roles in early pregnancy remain to be investigated. I also identified small but significant increases in the levels of miR-125b, let-7f, miR-145 and miR-99a-5p at oestrus, when compared with the luteal phase of the cycle. These miRNAs have been previously shown to regulate the follicular to luteal transition in the bovine ovary. Finally, I provide a validated high-throughput resource which can help identify potential global biomarkers of tissue function, as shown for the liver-enriched miR-802 in the present results. The findings of this work may be useful in the development of diagnostic methods for early pregnancy and oestrus, and pave the way for the functional characterisation of these miRNAs in bovine reproduction.

The Dairy industry requires accurate detection of oestrus(heat) in dairy cows to maximise output of the animals. Traditionally this is a process dependant on human observation and interpretation of the various signs of heat. Many areas of the dairy industry can be automated, however the detection of oestrus is an area that still requires human experts. This thesis investigates the application of Machine Learning classification techniques, on dairy cow milking data provided by the Livestock Improvement Corporation, to predict oestrus. The usefulness of various ensemble learning algorithms such as Bagging and Boosting are explored as well as specific skewed data techniques. An empirical study into the effectiveness of classifiers designed to target skewed data is included as a significant part of the investigation. Roughly Balanced Bagging and the novel Under Bagging classifiers are explored in considerable detail and found to perform quite favourably over the SMOTE technique for the datasets selected. This study uses non-dairy, commonplace, Machine Learning datasets; many of which are found in the UCI Machine Learning Repository.

The metabolism of androgenic anabolic steroids has been studied in the racing greyhound. Various drug preparations have been investigated utilising different derivatisation techniques, coupled with gas chromatographic analysis, to enable the identification of key metabolites in canine post administration samples. This has led to an increased understanding of some of the generic routes of steroid metabolism that take place in the greyhound. This valuable information can help to support metabolism studies in the future. The identification of specific metabolites for each compound investigated, has provided a means for controlling the misuse of these compounds, and contributed valuable enhancements to screening protocols utilised in the canine sports drug testing industry. Utilisation of the techniques described, resulted in the identification of specific major metabolites of the anabolic steroid methyltestosterone, namely 17??-methyl-5??- androstan-3??-17??-diol and 17??-methyl-5??-androstan-3??,16??,17??-triol. 16??- hydroxylation was shown to be a major phase I metabolic pathway in the canine along with phase II conjugation with glucuronic acid. Similar results were obtained during the metabolism study of the progestatgenic steroid norethisterone. Several di- and trihydroxy metabolites were detected in the glucuronic acid fraction of the post administration urines from this study. The norethisterone metabolism study also provided some insight, into the area of trace contaminants of pharmaceutical preparations. Low levels of nandrolone metabolites were also detected in the norethisterone post administration urine samples, leading to the discovery that the administered pharmaceutical tablets contained small quantities of nandrolone and 19- norandrostenedione, albeit below FDA approved contaminant levels. Modern methods of drug screening employ such highly sensitive techniques, that they allow for the detection of metabolites of such trace contaminants, following administration of the drug preparation to the greyhound. It is therefore important to have a broad understanding of the metabolism of various drug preparations, both banned and permitted substances alike; as detection of a trace amount of a banned substance metabolite, arising from the administration of a permitted medication, whose iii metabolite profile is unknown, and therefore potentially not detected, could present an interesting case. In conjunction with research into controlling the use of banned substances for the purposes of suppressing oestrus in the greyhound bitch, an investigation into normal/reference levels of endogenous hormones has been carried out. The endogenous steroid levels in a population of 212 greyhound bitches have been studied with a view to establishing a method for the detection of the exogenous administration of the endogenous anabolic steroid testosterone. The major urinary metabolites investigated were epiandrosterone, 5??-androstane-3??,17??-diol and 5??-androstane-3??,17??-diol. Statistical evaluations have been carried out to support the implementation of a suitable threshold for the key testosterone metabolites, namely 5??-androstane-3??,17??-diol and epiandrosterone. The detection of 5??-androstane-3??,17??-diol was found to be a very good indicator of the exogenous administration of testosterone to the greyhound bitch, when compared with the reference population data for this metabolite. However, further statistical/analytical data evaluation was deemed necessary before an absolute threshold could be implemented for this analyte, for the purposes of controlling the misuse of testosterone in the racing greyhound bitch. To support the understanding of endogenous steroid levels in the female greyhound, yet further, the endogenous reproductive steroid profiles were measured throughout the entire oestrus cycle of a cohort of 33 racing bitches. The results of the study clearly indicate a surge in androgen metabolites during the first 7-10 days of the oestrus cycle, in particular epiandrosterone and 5??-androstane-3??,17??-diol. This unique set of data has provided detailed information regarding the fluctuating concentrations of androgen and progesterone metabolites (following ovulation), at key stages of the canine oestrus cycle. The information obtained from this research can be used to support regulatory decisions regarding the misuse of testosterone in the racing greyhound bitch.

Intrauterine Bälle („small uterine device“; IUDs) sind aus Glas, Plastik oder Metall und wer-den vaginal in den Uterus eingeführt. Bei Stuten werden IUDs im Turniersport zur Unterdrü-ckung der unerwünschten Verhaltensänderungen während der Rosse eingesetzt. Der Einsatz ist einfach, günstig und minimal invasiv. Der Effekt wird durch eine Verlängerung der primären lutealen Phase erzielt, wobei jedoch der exakte Ablauf des Wirkmechanismus bisher ungeklärt ist. Hypothesen wie eine Scheinträchtigkeit, ein Placeboeffekt bei den Besitzern und eine chronische Endometritis werden in der Literatur diskutiert. Für die Untersuchung wurden 30 Stuten in vier Gruppen (G) eingeteilt: G1: KB (künstlich besamt) und tragend (n=8); G2: KB, nicht-tragend (zyklisch; n=7); G3: IUD, verlängerte luteale Phase (n=7) IUD-P (IUD-Positiv); G4: IUD, reguläre luteale Phase (n=8) IUD-N (IUD-Negativ). Die Uterusbiospien wurden am Tag 15 post ovulationem entnommen. Das Ziel der Studie war, mittels immunhistologischer Untersuchungen die Expression des Enzyms Cyclooxygenase 2 (COX2), verschiedener uteriner Proteine (Uteroglobin, Uterofer-rin, Uterokalin), Hormonrezeptoren (Östrogen-, Progesteronrezeptor) und des Proliferations-markers Ki-67 Antigen in endometrialen Biopsien bei IUD-Stuten darzustellen sowie die erhobenen Befunde mit den Ergebnissen am equinen Endometrium künstlich besamter Stuten zu vergleichen. Weiter wurde in den Endometriumbioptaten das Auftreten von Entzündungszellen analysiert (neutrophile und eosinophile Granulozyten, Mastzellen, Lymphozyten, Plasmazellen und Makrophagen). Die statistische Auswertung erfolgte mittels SPSS (SPSS Software-GmbH München). Hinsichtlich der Altersverteilung sind die Stuten der Gruppe 1 (KB/tragend) jünger als Tiere der Gruppe 2 (KB/nicht-tragend). Ein entsprechendes Ergebnis kann für die Stuten der Grup-pe 3 (IUD-P) im Vergleich zu den Tieren der Gruppe 4 (IUD-N) erhoben werden. Darüber hinaus sind Angiopathien bei den Pferden der Gruppe 1 bzw. 3 geringer ausgeprägt als bei den Stuten der Gruppe 2 bzw. 4. Immunhistologisch sind die endometrialen Drüsenzellen der Tiere aus Gruppe 1 durch eine maximale Uterokalin-(UK)-Expression gekennzeichnet, wohingegen Uteroferrin (UF) ledig-lich schwach exprimiert wird. Eine COX2-Expression kann bei diesen Stuten nicht beobachtet werden. Im Vergleich zu den graviden Pferden (Gruppe 1) zeigen künstlich besamte, nicht-tragende Stuten (Gruppe 2) zwar eine ausgeprägte UF- und COX2-Expression, UK wird dagegen lediglich gering exprimiert. Die KB-tragenden (Gruppe 1) und nicht-tragenden (Gruppe 2) Tiere sind somit durch eine ihrem Reproduktionszyklus entsprechende Expression der genannten Marker gekennzeichnet. Die IUD-Stuten (Gruppe 3 und 4) dagegen zeigen eine variable COX2, UF- und UK-Expression. Keine statistisch signifikanten Unterschiede sind zwischen allen Gruppen in der UG- und der Ki-67 Antigen-Expression nachweisbar. Stuten mit einer verlängerten lutealen Phase (Gruppe 1 und 3) und hohen Progesteronwerten im Serum besitzen eine geringere ER- und PR-Expression als die Versuchstiere mit einer regulären lutealen Phase (Gruppe 2 und 4) und einer Östrogendominanz. Die Auszählung der Entzündungszellen zeigt keine statistisch signifikanten Unterschiede hinsichtlich der Anzahl von neutrophilen und eosinophilen Granulozyten, Mastzellen, Plasmazellen sowie Lymphozyten zwischen den Gruppen. Im Stratum compactum ist die Zahl der Makrophagen in Gruppe 1 (tragend) signifikant höher als in Gruppe 2 (zyklisch), ebenfalls zeigt sich ein Anstieg dieser Zellen von der Gruppe 4 zu 3, allerdings ist diese Erhöhung nicht statistisch signifikant. Ein Placeboeffekt bei den Besitzern kann nahezu ausgeschlossen werden, da die Expression der Proteine (UF, UK) und COX2 in den IUD-Stuten, im Vergleich zu den KB-Stuten, signi-fikante Unterschiede aufweist. Da im eigenen Untersuchungsgut zwischen den tragenden Stuten (Gruppe 1) und den IUD-Stuten der Gruppe 3 (vlP)/“Scheinträchtigkeit“ ein signifikant unterschiedliches Expressionsverhalten hinsichtlich des Enzyms COX2 und des Proteins UF besteht, kann die Hypothese einer Scheinträchtigkeit ebenso als unwahrscheinlich eingestuft werden. Bei keiner der IUD-Stuten konnte eine chronische Endometritis nachgewiesen werden, somit ist auch diese Hypothese als Ursache des IUD-Effektes eher unwahrscheinlich. Die erhöhte Anzahl an Makrophagen in der Gruppe 3 könnte jedoch hinweisend auf einen lokalen Effekt der IUDs im Sinne einer Fremdkörperreaktion sein. Da hinsichtlich des Auftretens einer Endometritis zwischen resistenten und empfänglichen Tieren unterschieden wird, könnte somit die erhöhte Anzahl an Makrophagen in der Gruppe 3 möglicherweise als Hinweis auf „Endometritis empfängliche Stuten“ gewertet werden und dies eine Ursache für die variierende Wirksamkeit der Rosseunterdrückung mittels IUDs darstellen. Die eigenen Untersuchungen zeigen ferner, dass die IUD-Stuten mit verlängerter lutealer Phase (IUD-positive Wirkung, Gruppe 3) jünger sind im Vergleich zu den Tieren, die trotz IUD eine Luteolyse (IUD-negative Wirkung, Gruppe 4) aufweisen. Zudem weisen die IUD-P Tiere geringere An-giopathien auf. Möglicherweise sind zudem das Alter und die Perfusion des Uterus bedeutend für die Wirksamkeit der IUDs in Equiden. Abschließend kann somit der Wirkmechanismus der IUDs auch mittels der durchgeführten Untersuchungen nicht endgültig geklärt werden. Unter Berücksichtigung der erhobenen Be-funde sollten zukünftige Studien insbesondere Untersuchungen zu Entzündungsmediatoren, wie z.B. Zytokine, beinhalten.

My work was focused on assesment of moving activity of beef cattle (whole year outdoor lairage) with special aim at outward and inward factors. Experiment was realized in a small privat farm (40ha) in foothills. Breeding animals are crossbreeds of these beef cattle races: charolais, piemontese, aberdeen angus, hereford, gasconne, limusine and czech pied cows.

In this study 272 beef heifers were studied from just prior to their first breeding season (15 October 2003), through their second breeding season and until just after they had weaned their first calves in March 2005. The study consisted of two main parts: in the first part, heifers were randomly allocated to either a synchronised TEST group or an unsynchronised CONTROL group. The TEST group received artificial insemination (AI) for 6 days followed by prostaglandin F2á (PGF) treatment on day 6 (PGF/6) and further AI for a total of 50 days, which was followed after a 6 day break by a 42 day bull breeding season. The CONTROL group were bred for the same period without PGF treatment. Synchronisation resulted in a reduction in days to first insemination (P < 0.01) and days to calving (P = 0.04). No significant difference could be demonstrated in pregnancy rate to the 50 day AI season (60.0% vs. 51.8%, TEST and CONTROL groups respectively, P = 0.18), final pregnancy rate (82.2% vs. 83.2%, P = 0.87) or pregnancy rate to the subsequent breeding season (96.0% vs. 95.0%, P = 1.00). A significant increase in mean weaning mass of the calves due to synchronisation could not be demonstrated (207.0 kg vs. 201.4 kg, TEST and CONTROL groups respectively, P = 0.32). However, data from this study were used to calculate the benefit:cost ratio, and a value of 2.8 was reached, representing the return on investment for the synchronisation protocol under these circumstances. It was concluded from this study that a PGF/6 protocol may lead to a change in the total mass of calves weaned by changing days to calving and thus weaning mass, birth mass of calves, weaning rate and/or the ratio of male:female calves born. It was further concluded that a practical way to predict the cost effectiveness of an oestrus synchronisation protocol is to determine the ratio between the total cost of the programme and the price of weaner calves per kg live mass. This ratio represents the minimum increase in mean weaning mass that has to be achieved for the programme to be cost effective if no increase in weaning rate is achieved. In the second part of this study, reproductive tract scoring (RTS) was performed on the same group of heifers one day before the onset of their first breeding season. The effect of RTS on several reproduction and production outcomes was tested, and the association of RTS with the outcomes was compared to the associations of other input variables such as mass, age, body condition score (BCS) and Kleiber ratio using multiple or univariable linear or logistic regression. RTS was associated with pregnancy rate to the 50 day AI season (P < 0.01), days to calving (r = 0.28, P < 0.01), calf weaning mass (r = 0.22, P < 0.01) and pregnancy rate to the subsequent breeding season (P < 0.01). These associations were mostly independent of associations with mass, age and BCS before the onset of the first breeding season. RTS was a better predictor of fertility than was Kleiber ratio, and similar in its prediction of calf weaning mass. It was concluded from this study that RTS is a unique predictor of heifer fertility, compares well with (but is independent of) other traits used as a predictor of production outcomes and is likely to be a good predictor of life production of the cow. / Dissertation (MSc (Veterinary Sciences))--University of Pretoria, 2006. / Production Animal Studies / unrestricted

No / Previous studies in this laboratory have suggested that the isolated uterus from non-pregnant mice has a prostaglandin F and a thromboxane receptor population similar to that found in human myometrium. The aim of this study was to investigate any regional variation in myogenic activity ) and the and responsiveness to prostaglandin F(2alpha) (PGF(2alpha) thromboxane mimetic U46619 in the mouse uterus taken during different stages of the oestrous cycle and during pregnancy. Uterine samples from BKW mice were taken from different anatomical segments along the length of each uterine horn and set up for superfusion at 2 ml/min with Krebs solution (containing 1 microM indometacin) at 37 degrees C, and gassed with 95%O(2)/5%CO(2). Responses (area under the curve) are expressed as a percentage of the final contraction induced by hypotonic shock. Data are expressed as the means +/- s.e.m. of n=5-12 and were analysed using Student's paired t-test or two-way ANOVA with a Bonferroni post hoc test. Regional variation in myogenic activity was observed in all tissues studied except those taken during labour. These tissues displayed significantly greater myogenic activity than tissues taken at late gestation and at all stages of the oestrous cycle. Tissues from pregnant animals were generally more responsive to U46619 and PGF(2alpha) than tissues taken from non-pregnant animals. Tissues taken from the upper segment of the uterine horn were more responsive to both agonists during the oestrous cycle. The findings demonstrated that the hormonal milieu and site of excision are important for myogenic activity and responsiveness.